⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Global Critical Infrastructure Protection (CIP) Market Forecast, 2026-2031 | AI, Digital Twins, and OT Security Drive Growth to USD 206.31 Billion
globenewswire.com
FCEL
FTNT
CSCO
LMT
GD
NOC
HON
SNOW
GE
T
VZ
AVGO
AMD
NVDA
MSFT
GOOG
AMZN
IBM
PANW
CRWD
DDOG
ETSY
PLTR
SMCI
QCOM
INTC
MU
AMAT
LRCX
ASML
ADI
TXN
MRVL
NXPI
ON
STM
INFY
ACN
HPQ
DELL
CDNS
SNPS
MCHP
AEHR
TER
AMKR
WDC
SE
BABA
JD
NTES
PDD
IQ
BEKE
RBLX
EXAS
REGN
GILD
BMY
AMGN
VRTX
AZN
MRK
LLY
SNY
ABBV
BIIB
XRAY
ISRG
MDLZ
ADM
KHC
PEP
KO
MCD
SBUX
YUM
CMG
NKE
LULU
BBY
TJX
HD
LOW
COST
WMT
GOOGL
AAPL
META
NFLX
DIS
CMCSA
S
BA
AIR
TH
TENB
CLAR
BAC
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026
prnewswire.com
INCY
MRNA
ALNY
BMY
BIIB
Global Neurology Digital Health Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Digital Therapeutics, and Remote Care Create Scalable Growth Opportunities
globenewswire.com
TDOC
MDT
PHG
GEHC
ABT
BIIB
Active Pharmaceutical Ingredients (API) Market 2026-2034: Global Size, Share, Growth and Company Analysis | Generics, Biologics and Outsourcing Drive Value to $400.94 Billion
globenewswire.com
TEVA
BIIB
PFE
BMY
LLY
MRK
ABBV
Global Oligonucleotide Synthesis Market Forecast to 2031 | Market to Reach US$32.72 Billion at 17.4% CAGR as RNA Therapeutics and Molecular Diagnostics Scale
globenewswire.com
DHR
TMO
MAR
AZTA
TWST
BIIB
ALNY
SRPT
IONS
Perceive Biotherapeutics Completes Enrollment in Phase 2a JOURNEY Study of VOY-101 Gene Therapy for Geographic Atrophy and Appoints Tony Gibney to Board of Directors
prnewswire.com
BIIB
ASTL
Global CEOs to explore new opportunities in Shanghai
prnewswire.com
NVS
BIIB
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape | DelveInsight
prnewswire.com
LLY
REGN
LSTA
ABT
PFE
JNJ
MRK
BMY
AZN
NVS
AMGN
GILD
BIIB
Global Gene Therapy Market Size, Share, Growth, and Forecast 2026-2035 | USD 74.78 Billion Opportunity Driven by Rare Disease R&D, Viral Vectors, and Regulatory Approvals
globenewswire.com
AMGN
BIIB
GILD
SANG
NTLA
RPTX
EDIT
CRSP
GNPX
ASTL
Anirvan Ghosh Joins Formation Bio as SVP, Head of Translational Sciences
prnewswire.com
BIIB